IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome.

about

IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome.

Item

http://www.wikidata.org/entity/Q41989805

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

IFI16 restoration in hepatocel ...... p53 signals and inflammasome.

@en

type

Item

label

IFI16 restoration in hepatocel ...... p53 signals and inflammasome.

@en

prefLabel

IFI16 restoration in hepatocel ...... p53 signals and inflammasome.

@en

P1476

IFI16 restoration in hepatocel ...... f p53 signals and inflammasome

@en

P2093

Shijun Chen

http://www.w3.org/2001/XMLSchema#string

Wei Lin

http://www.w3.org/2001/XMLSchema#string

Yaxin Zhao

http://www.w3.org/2001/XMLSchema#string

Zhiguang Zhao

http://www.w3.org/2001/XMLSchema#string

Zhonglin Ni

http://www.w3.org/2001/XMLSchema#string

P2860

IFI16 is an innate immune sensor for intracellular DNA

IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection

Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1

Current and future treatments for hepatocellular carcinoma

The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation

Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation

Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth

Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta

TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.

Hepatocellular carcinoma: clinical frontiers and perspectives.

P31

scholarly article

P356

10.1111/CPR.12392

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wenjun Du

P577

2017-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28990231

http://www.w3.org/2001/XMLSchema#string

P921

inflammasome

P932

6529087

http://www.w3.org/2001/XMLSchema#string